Research Solutions, Inc.
Business
Research Solutions is a vertical SaaS and AI company providing cloud-based software platforms and services to help research-intensive organizations simplify and manage the research process. The company offers three integrated platform solutions—Discovery Tools (search and discovery), Access (article acquisition and rights management), and Manage (reference and document management)—along with transactional sales of scientific, technical, and medical (STM) articles. The platforms serve corporate, academic, government, and individual researchers globally, with revenue derived from annual or monthly subscription licenses and per-transaction article delivery fees.
Summary from 10-K filed 2025-09-19
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Total revenue | 49 | 45 | 38 | 33 | 32 | |
| Total cost of revenue | 25 | 25 | 23 | 21 | 21 | |
| Gross profit | 24 | 20 | 15 | 12 | 10 | |
| Selling, general and administrative | 20 | 20 | 14 | 14 | 11 | |
| Depreciation and amortization | 1 | 836,271 | 52,649 | 17,651 | 11,522 | |
| Total operating expenses | 22 | 20 | 14 | 14 | 11 | |
| Income (loss) from operations | 3 | −769,543 | 238,608 | −2 | −283,032 | |
| Other income | 595,679 | 333,088 | 338,617 | 7,154 | 1,147 | |
| Change in fair value of contingent earnout liability | −2 | −3 | 0 | — | — | |
| Income (loss) before provision for income taxes | 1 | −4 | 577,225 | −2 | −281,885 | |
| Provision for income taxes | −82,811 | −113,071 | −5,602 | −7,622 | −3,204 | |
| Net income (loss) | 1 | −4 | 571,623 | −2 | −285,089 | |
| Foreign currency translation | −1,368 | −595 | 3,717 | −2,364 | 5,461 | |
| Comprehensive income (loss) | 1 | −4 | 575,340 | −2 | −279,628 | |
| Net income (loss) per share (in dollars per share) | 0.04 | −0.13 | 0.02 | −0.06 | — | |
| Weighted average common shares outstanding | 31 | 29 | 27 | 26 | — | |
| Net income (loss) per share (in dollars per share) | 0.04 | −0.13 | 0.02 | −0.06 | — | |
| Weighted average common shares outstanding | 32 | 29 | 29 | 26 | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 12 | 6 | 14 | 11 | 11 | |
| Accounts receivable, net of allowance of $182,324 and $68,579, respectively | 7 | 7 | 6 | 5 | 5 | |
| Prepaid expenses and other current assets | 580,257 | 643,553 | 400,340 | 276,026 | 270,252 | |
| Prepaid royalties | 925 | 1 | 1 | 846,652 | 904,921 | |
| Total current assets | 20 | 15 | 21 | 17 | 17 | |
| Property and equipment, net of accumulated depreciation of $964,883 and $922,558, respectively | 60,769 | 88,011 | 70,193 | 47,985 | 20,755 | |
| Intangible assets, net of accumulated amortization of $2,736,773 and $1,535,310, respectively | 10 | 11 | 462,068 | 0 | — | |
| Goodwill | 16 | 16 | 0 | — | — | |
| Deposits and other assets | 957 | 981 | 1,052 | 893 | 906 | |
| Total assets | 46 | 42 | 22 | 17 | 17 | |
| Accounts payable and accrued expenses | 7 | 9 | 8 | 7 | 7 | |
| Deferred revenue | 11 | 9 | 6 | 6 | 5 | |
| Contingent earnout liability, current portion | 7 | 0 | — | — | — | |
| Total current liabilities | 26 | 18 | 15 | 12 | 11 | |
| Contingent earnout liability, long-term portion | 7 | 12 | 0 | — | — | |
| Total liabilities | 32 | 30 | 15 | — | — | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock; $0.001 par value; 100,000,000 shares authorized; 32,479,993 and 32,295,373 shares issued and outstanding, respectively | 32,480 | 32,295 | 29,487 | 27,076 | 26,498 | |
| Additional paid-in capital | 39 | 38 | 30 | 28 | 27 | |
| Accumulated deficit | −25 | −26 | −23 | −23 | −21 | |
| Accumulated other comprehensive loss | −120,187 | −118,819 | −118,224 | −121,941 | −119,577 | |
| Total stockholders' equity | 14 | 12 | 7 | 5 | 5 | |
| Total liabilities and stockholders' equity | 46 | 42 | 22 | 17 | 17 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 1 | 836,271 | 52,649 | 17,651 | 11,522 | |
| Stock options expense | 205,457 | 140,150 | — | — | — | |
| Restricted common stock expense | 2 | 2 | 1 | 557,496 | 376,338 | |
| Modification cost of accelerated vesting of restricted common stock | 0 | 20,949 | 56,000 | — | — | |
| Accounts receivable | −341,434 | −344,020 | −901,518 | −534,092 | −268,193 | |
| Prepaid expenses and other current assets | 63,296 | −164,579 | −124,314 | −5,774 | −28,505 | |
| Prepaid royalties | 1 | 135,441 | −356,026 | 58,269 | −184,554 | |
| Accounts payable and accrued expenses | −1 | 560,027 | 1 | −83,156 | 337,343 | |
| Deferred revenue | 2 | 921,879 | 886,198 | 734,175 | 1 | |
| Net cash provided by operating activities | 7 | 4 | 3 | −417,200 | 2 | |
| Purchase of property and equipment | −19,261 | −71,510 | −47,209 | −44,288 | −19,854 | |
| Net cash used in investing activities | −19,261 | −10 | −344,659 | −44,288 | −19,854 | |
| Proceeds from the exercise of stock options | 180,800 | 0 | 57,500 | 97,688 | 88,850 | |
| Common stock repurchase | −934,577 | −554,202 | −104,250 | −93,918 | −178,012 | |
| Payment of contingent acquisition consideration | −124,107 | −351,649 | −50,509 | 0 | — | |
| Net cash used in financing activities | −877,884 | −905,851 | −97,259 | 63,270 | −159,974 | |
| Effect of exchange rate changes | 1,260 | 4,851 | 229 | −2,944 | 4,203 | |
| Net increase (decrease) in cash and cash equivalents | 6 | −7 | 3 | −401,162 | 2 | |
| Cash paid for income taxes | 82,811 | 113,071 | 5,602 | 7,622 | 3,204 | |
| Contingent consideration accrual on asset acquisition | 31,359 | 32,022 | 138,428 | 0 | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Research Solutions, Inc.'s CIK number?
Research Solutions, Inc.'s SEC CIK number is 0001386301 (1386301). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Research Solutions, Inc.'s SEC filings?
All of Research Solutions, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Research Solutions, Inc. last report earnings?
Research Solutions, Inc. (RSSS) most recently filed an earnings 8-K with the SEC on May 14, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001104659-26-061215). This is Research Solutions, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Research Solutions, Inc.'s most recent earnings 8-K?
Research Solutions, Inc.'s latest earnings 8-K (Item 2.02) was filed May 14, 2026 under accession 0001104659-26-061215. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Research Solutions, Inc.'s latest earnings 8-K →
Look up any company's CIK number →